Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,600
Closed -$140K 1351
2025
Q2
$140K Sell
1,600
-18,700
-92% -$1.47M 0.01% 858
2025
Q1
$1.39M Buy
20,300
+9,800
+93% +$800K 0.06% 391
2024
Q4
$817K Sell
10,500
-15,400
-59% -$1.14M 0.03% 514
2024
Q3
$1.74M Buy
25,900
+4,200
+19% +$345K 0.06% 372
2024
Q2
$2.46M Buy
21,700
+18,000
+486% +$2.28M 0.09% 285
2024
Q1
$513K Buy
+3,700
New +$465K 0.02% 734

Other funds holding DXCM

Point72 (DIFC)'s DXCM Position: Q3 2025 in Review

Point72 (DIFC) increased its DexCom (DXCM) stake by 89% in Q3 2025, buying an estimated $11.7M and bringing the position to 312,430 shares worth $21M. The position accounts for 1.38% of the portfolio, ranked #14.

Point72 (DIFC) first reported a position in DXCM in Q1 2025 and has held it in 3 quarters since. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Point72 (DIFC) held 312,430 shares of DexCom worth $21M as of Q3 2025.
  • Point72 (DIFC) bought 147,230 DexCom shares in Q3 2025, an estimated $11.7M.
  • DexCom made up 1.38% of Point72 (DIFC)'s portfolio in Q3 2025, its #14 holding.
  • Point72 (DIFC) first reported a position in DexCom in Q1 2025 and has held it in 3 quarters since.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.